NewKerala.com

Key Points

Vijaya Diagnostic Centre experienced a slight dip in quarterly net profit while maintaining steady revenue growth. The company's expenses increased by 13.8%, reflecting broader market challenges in the healthcare diagnostics sector. Despite the quarterly fluctuation, the full fiscal year performance showed a robust 20.41% rise in net profit. The diagnostic chain, founded in 1981 in Hyderabad, continues to operate 125 centers with a professional team of over 2,200 experts.

Key Points: Vijaya Diagnostic Q4 Profit Dips 1.41% Despite Revenue Growth

  • Q4 net profit drops 1.41% to Rs 34.8 crore
  • Total expenses rise 13.8% to Rs 130.4 crore
  • Revenue increases 11.6% to Rs 173.2 crore
  • Annual net profit jumps 20.41% to Rs 143.08 crore
2 min read

Vijaya Diagnostic Centre's profit dips in Q4, expenses rise 13.8 pc

Vijaya Diagnostic Centre reports Q4 earnings with rising expenses and modest revenue increase amid challenging financial landscape

"We maintain 125 state-of-the-art diagnostic centres across 20 cities - Vijaya Diagnostic Centre Annual Report"

New Delhi, May 12

Vijaya Diagnostic Centre Limited on Monday reported nearly 1.41 per cent drop in net profit in Q4 of the last financial year at Rs 34.8 crore, from Rs 35.3 crore in the previous quarter (Q3 FY25).

The company's total expenses in Q4 were up by nearly 13.8 per cent at Rs 130.4 crore, from Rs 114.6 crore in the year-ago period, according to its stock exchange filing.

The pathology lab saw its revenue up by 11.6 per cent in Q4 at Rs 173.2 crore, from Rs 155.2 crore in the same period in FY24.

For the full fiscal, net profit rose 20.41 per cent to Rs 143.08 crore in the year ended March 2025, as against Rs 118.83 crore during the previous year ended March 2024.

The share of the company ended almost flat, down by Rs 3.1 or 0.31 per cent to Rs 990 on the National Stock Exchange (NSE) on Monday.

Vijaya Diagnostic's share price has declined by 2.04 per cent, or Rs 20.60, over the past five days.

In the last one month, the stock has fallen by 1.03 per cent, equivalent to Rs 10.30. Over the past six months, the share price has dropped by 7.46 per cent, or Rs 79.75. On a year-to-date (YTD) basis, the stock is down by 6.85 per cent, reflecting a loss of Rs 72.75 on the NSE.

The company claims to have 125 state-of-the-art diagnostic centres located in 20 cities, with in-house team that has more than 2,200 professionals -- pathologists, radiologists and microbiologists.

Started in 1981 in Hyderabad, Vijaya Diagnostic Centre is the brainchild of Dr S. Surendranath Reddy.

Meanwhile, in a new executive order, US President Donald Trump has vowed to cut the price of prescription drugs and pharmaceuticals in the US between 30 per cent to 80 per cent. He also cited years of frustration of US consumers in paying significantly higher prices for medications than people in other countries.

- IANS

Share this article:

Reader Comments

R
Rahul K.
The profit dip is concerning but revenue growth shows people still trust Vijaya for diagnostics. Their network across 20 cities is impressive! Maybe they're investing in expansion which explains higher expenses. Long term investors shouldn't panic. 💉
P
Priya M.
Used their services last month - good quality but expensive compared to local labs. If expenses are rising, will they increase prices further? Middle class families like mine will suffer. Healthcare shouldn't only be about profits.
A
Arjun S.
Stock market reacts to short-term numbers but FY25 profit grew 20%! That's solid. Vijaya is a trusted brand since 1981. Temporary blips happen in healthcare sector. Trump's comments on drug prices interesting - hope India follows similar cost control measures.
S
Sunita R.
Their reports are accurate but waiting time has increased at centers. With 2,200 professionals, they should improve customer experience. Maybe expenses going into salaries not service improvement? Just my observation as regular customer.
V
Vikram J.
Diagnostic business is recession-proof but competition increasing. New players like Metropolis, Dr Lal giving tough fight. Vijaya needs to maintain quality while controlling costs. 13.8% expense rise too high when profit dipping. Tighten belts!
N
Neha P.
Healthcare stocks always volatile. What matters is Vijaya's 125 centers provide jobs to thousands and quality diagnostics to lakhs of patients. Short term numbers don't reflect their social impact. Proud of this Hyderabad-origin company going national! 💪

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50